BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 3879107)

  • 1. Non-Hodgkin's lymphomas of the lung. A study of 19 cases emphasizing the utility of frozen section immunologic studies in differential diagnosis.
    Weiss LM; Yousem SA; Warnke RA
    Am J Surg Pathol; 1985 Jul; 9(7):480-90. PubMed ID: 3879107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Hodgkin's lymphomas: an immunohistochemical and histological study.
    Curran RC; Jones EL
    J Pathol; 1979 Dec; 129(4):179-90. PubMed ID: 317105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical determination of CD23 expression in Hodgkin's disease using paraffin sections.
    Rowlands DC; Hansel TT; Crocker J
    J Pathol; 1990 Mar; 160(3):239-43. PubMed ID: 2139890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
    Pinkus GS; Said JW
    Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical typing of non-Hodgkin's lymphoma-comparing working formulation and WHO classification.
    Kalyan K; Basu D; Soundararaghavan J
    Indian J Pathol Microbiol; 2006 Apr; 49(2):203-7. PubMed ID: 16933715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical approach to the immunodiagnosis of lymphomas emphasizing differential diagnosis.
    Warnke RA; Weiss LM
    Cancer Surv; 1985; 4(2):349-58. PubMed ID: 3879857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies marking B-cell non-Hodgkin's lymphoma in paraffin-embedded tissue.
    Linder J; Ye Y; Armitage JO; Weisenburger DD
    Mod Pathol; 1988 Jan; 1(1):29-34. PubMed ID: 3266335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
    Davey FR; Goldberg J; Stockman J; Gottlieb AJ
    Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of human lymphomas with monoclonal antibodies to B cell and Ia antigens reactive in paraffin sections.
    Marder RJ; Variakojis D; Silver J; Epstein AL
    Lab Invest; 1985 May; 52(5):497-504. PubMed ID: 3887032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical staining of non-Hodgkin's lymphoma with monoclonal antibodies specific for the leucocyte common antigen.
    Salter DM; Krajewski AS; Dewar AE
    J Pathol; 1985 Aug; 146(4):345-53. PubMed ID: 2411901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Hodgkin's lymphomas. analysis of 109 Japanese cases with the use of LSGJ classification.
    Shimizu M; Miura M; Kitahara M; Katayama I
    Am J Pathol; 1982 Jan; 106(1):30-9. PubMed ID: 7034544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistologic cellular phenotypes of lymphoproliferative disorders. Comprehensive evaluation of 564 cases including 257 non-Hodgkin's lymphomas classified by the International Working Formulation.
    Tubbs RR; Fishleder A; Weiss RA; Savage RA; Sebek BA; Weick JK
    Am J Pathol; 1983 Nov; 113(2):207-21. PubMed ID: 6605690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological markers in non-Hodgkin's lymphomas.
    Gobbi M; Mazza P; Mantovani W; Fiacchini M; Lauria F; Tura S
    Boll Ist Sieroter Milan; 1979 Nov; 58(5):410-5. PubMed ID: 399843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-Hodgkin's lymphoma: correlation of cell surface marker phenotype with clinical features and prognosis].
    Okabe K; Toki H; Kimura Y; Fujii M; Kiura K; Moriwaki S
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2960-4. PubMed ID: 3490224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to differentiate between T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease. Evidence for the value of MB1 and 4KB5 immunostaining.
    Schmidt U; Herbst J; Metz KA; Leder LD
    J Pathol; 1996 Jun; 179(2):138-44. PubMed ID: 8758204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage IE non-Hodgkin's lymphoma involving the dura: A clinicopathologic study of five cases.
    Miranda RN; Glantz LK; Myint MA; Levy N; Jackson CL; Rhodes CH; Glantz MJ; Medeiros LJ
    Arch Pathol Lab Med; 1996 Mar; 120(3):254-60. PubMed ID: 8629900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
    Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
    Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical staining of non-Hodgkin's lymphoma in paraffin sections using the MB1 and MT1 monoclonal antibodies.
    Dobson CM; Myskow MW; Krajewski AS; Carpenter FH; Horne CH
    J Pathol; 1987 Nov; 153(3):203-12. PubMed ID: 3323430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.